Evaluation of exposure risk for healthcare personnel performing the open technique HIPEC procedure using cisplatin.

[1]  J. Spiliotis,et al.  Operating personnel safety during the administration of Hyperthermic Intraperitoneal Chemotherapy (HIPEC). , 2016, Surgical oncology.

[2]  D. Nowak,et al.  Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC). , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  R. Garnier,et al.  Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure , 2011, Journal of surgical oncology.

[4]  D. Nowak,et al.  Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. , 2009, The Annals of occupational hygiene.

[5]  J. Esquivel.  Technology of Hyperthermic Intraperitoneal Chemotherapy in the United States, Europe, China, Japan, and Korea , 2009, Cancer journal.

[6]  L. Gladieff,et al.  [Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel]. , 2009, Bulletin du cancer.

[7]  B. Chauffert,et al.  Closed Hyperthermic Intraperitoneal Chemotherapy with Open Abdomen: a Novel Technique to Reduce Exposure of the Surgical Team to Chemotherapy Drugs , 2008, Annals of Surgical Oncology.

[8]  J. Pelz,et al.  Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  P. Sugarbaker,et al.  The approval process for hyperthermic intraoperative intraperitoneal chemotherapy. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  Michel Simonet,et al.  High Intra-abdominal Pressure Enhances the Penetration and Antitumor Effect of Intraperitoneal Cisplatin on Experimental Peritoneal Carcinomatosis , 2006, Annals of surgery.

[11]  P. Sugarbaker,et al.  Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations. , 1996, AORN journal.